155 results
Page 5 of 8
8-K
EX-99.1
34xq 4208
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
bzek7e
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
zr1wov6
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.1
4cn 4r2qyx5h5fg2x
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.2
1quq x5am
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-1.1
m246v3q6d
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
dj5j7dkp90 albk30
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
eda1mm6 es
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
zn1kg 920
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
EX-99.2
txl xford81e
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
EX-99.1
cwm1s o5i5alvv
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
qw383c
18 Mar 20
Automatic shelf registration
10:00pm
8-K
EX-99.2
gswzdj07w rgcfa7ra
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
ydq yt6yc5
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
ocma1zjxq5ncybp9z7
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm